Metformin reduces risk of OHSS in patients with PCO during gonadotropin-stimulated IVF cycles – a randomized controlled trial. (Article in-press at Fertility and Sterility Journal) [box type=”info”]Take Home Message [unordered_list style=”green-dot”] Metformin reduced the relative risk of OHSS to 28% (range = 11% – 67%) of that without metformin supplements The study had a very … Read More »
I have come to believe that one of the key factors that differentiates IVF outcomes is individualization and management of ovarian stimulation.
The authors suggest that AMH testing is useful for individualization of stimulation protocols in oocyte donors to maximize egg yields and to prevent OHSS. This conclusion makes great sense to me. Our goal in all IVF cycles (infertile and egg donors alike) is to maximize the number of quality eggs retrieved without causing complications such … Read More »